Luis Borges - 17 Jun 2021 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Scientific Officer
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
3
Filing time
17 Jun 2021, 17:01:25 UTC
Next filing
27 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IPSC Stock Option (right to buy) 17 Jun 2021 Common Stock 357,696 $1.03 Direct F1
holding IPSC Stock Option (right to buy) 17 Jun 2021 Common Stock 146,826 $7.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.
F2 The option vests 25% on the first anniversary of the closing of the Issuer's initial public offering, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.